The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.

Obesity-related cancer deaths most commonly occurred at medical facilities (n=16,243), followed by people’s homes (n=10,251), nursing and long-term care facilities (n=4446), and hospice (n=1492).

AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

HealthDay News — Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in the July issue of The Lancet ...

PCOS was associated with an increased risk for vascular events including stroke among women with thrombotic disease, and a ...

The FDA has cleared the Hilo Band (G0 Blood Pressure Monitoring System) for at-home blood pressure monitoring in adults.

HealthDay News — Pharmacologic treatment of hypercholesterolemia falls short of U.S. and European guidelines, according to a study published online June 30 in the Journal of General Internal Medicine.

HealthDay News — For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs), according to a study published ...

Maternal hypertension is linked to poorer cognitive, language outcomes in preterm 2-year-olds, partly due to early brain abnormalities.

Sweetener consumption and genetic predisposition are independently associated with the risk for central precocious puberty (CPP).

Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...